Petlife Pharmaceuticals: A Biotech Company Introducing a New, Organic-Cancer Drug Disrupting a Multibillion Pet Pharmacy Market

PetLife Pharmaceuticals (OTCQB: PTLF) is a registered US Veterinary Pharmaceutical company. This biotech company is offering a Private Placement to accredited investors. A 10% annual dividend is included. The monies will be used to obtain FDA registration of a new, organic-cancer drug for pets with limited to no harmful side effects. The drug has already been approved for human oncology in several countries. With this proven success Petlife is very confident with their registration process for pets. The value is estimated to be in the billions with the FDA approval. Learn about the Private Placement and becoming a shareholder in our public stock.